Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CREON for Glucose Regulation in Type 1 Diabetes
NCT05266963Phase 1Completed
- Sponsor
- Vanderbilt University Medical Center
- Start
- Sep 2022
- Primary completion
- Mar 2024
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in type 1 diabetes mellitus (T1D) comparing CREON Sequence with Placebo Sequence (2 arms). Primary endpoints: Improvement in Glucose Regulation at 5 weeks and Patient-reported Change in Pancreatic Exocrine Insufficiency Symptoms at 5 weeks. Started Sep 2022; status: completed.
02
Drugs
pancreatin
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT05266963.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05266963.